Market revenue in 2024 | USD 3,996.3 million |
Market revenue in 2030 | USD 5,554.2 million |
Growth rate | 5.7% (CAGR from 2025 to 2030) |
Largest segment | Non-cold chain logistics |
Fastest growing segment | Cold Chain Logistics |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cold Chain Logistics, Non-cold Chain Logistics |
Key market players worldwide | DHL Group, SF Express, United Parcel Service Inc Class B, AmerisourceBergen Drug Corporation, DB Schenker, Kuehne + Nagel International AG, Kerry Logistics Network Ltd, Agility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical third-party logistics market will help companies and investors design strategic landscapes.
Non-cold chain logistics was the largest segment with a revenue share of 81.96% in 2024. Horizon Databook has segmented the Canada biopharmaceutical third-party logistics market based on cold chain logistics, non-cold chain logistics covering the revenue growth of each sub-segment from 2018 to 2030.
Canada biopharmaceutical third party logistics market accounted for 7.2% share in 2020 in the North American market. According to the World Bank, the Logistics Performance Index (LPI) score of Canada was 3.73 in 2018. The country has a decent transportation system for biopharmaceutical third party logistics market.
For instance, according to OECD, 269,094 million tonne-km of freight transport was completed in the country in 2018. Favorable government initiatives in the country will also boost market growth. For instance, in 2021, Pfizer-BioNTech got authorization from Health Canada for storing COVID19 vaccines at temperatures between −25°C and −15°C for a duration of up to 2 weeks.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada biopharmaceutical third-party logistics market , including forecasts for subscribers. This country databook contains high-level insights into Canada biopharmaceutical third-party logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account